InvestorsHub Logo
Followers 244
Posts 12729
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Thursday, 12/07/2023 1:56:21 PM

Thursday, December 07, 2023 1:56:21 PM

Post# of 1106
More success with an IMGN developed product.

https://finance.yahoo.com/news/press-release-sarclisa-isatuximab-phase-063500551.html

I'm frankly uncertain how great IMGN's financial interest is in this, but clearly it's a greater indication of the value of their technology, and further indication that the buyout offer is too low.

I'm purchasing some out of the money future calls in hope that we'll get a better offer.

Gary